SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IMNR - Immune Response
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Robert DeHaven who wrote (179)11/24/1997 8:51:00 PM
From: MJ  Read Replies (1) of 1510
 
Robert and Mark:

Agree with Robert on one major point--that the stock (or any stock, often) moves up in advance of news.

Don't disagree on his other points, just don't know. I like the chart which gives a picture of the past and present action.

Assuming IMNR goes to about 17---then what? Wait and see and hold or sell? If they truly are on to something major with the clinical trials then it would seem to me that even at 17 I would hold for higher prices.

MJ
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News